INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Fondazione Policlinico Universitario A. Gemelli – Roma, Italy

In this page

How to contact the center

Full member

HCP Center

The Fondazione Policlinico Universitario Agostino Gemelli IRCCS is the place where scientific and technical skills, human sensitivity and Catholic ethics and values become a motivating commitment at the service of everyone, in order to guarantee excellent and affordable treatments to the entire community.

The Fondazione’s mission, being a Policlinico Universitario with Catholic inspirations, is to offer patients humanity, excellent and highly specialized treatments by promoting continuous medical innovation and training future medical professionals.

The Fondazione is the place where scientific and technical skills, human sensitivity, Catholic ethics and values become a genuine commitment at the service of everyone, in order to guarantee excellent and affordable treatments to the entire community.

The Policlinico Gemelli and the School of Medicine are placed at the heart of the health system, by developing and spreading a national and international reference model regarding the management, organization, technology and humanization of the medical field.

Picture :Sergio D’Afflitto, CC BY-SA 3.0 IT, via Wikimedia Commons

Contact

Fondazione Policlinico Universitario A. Gemelli – Roma, Italy

Via della Pineta Sacchetti, 217
168 Roma RM
Italy

Team

Pr Benedetto Falsini

Representative

Italy

See more

Pr Angelo Maria Minnella

Substitute

Italy

See more

Clinical trials

NCT05987423 - Active, Not recruiting

A Phase III, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Moderate-To-Severe Thyroid Eye Disease

Interventional
See the trial
voir la fiche

NCT04525261 - Completed

Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene

Observational
See the trial
voir la fiche
NCT02110225 - Completed

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy ofrhNGF in Patients With Retinitis Pigmentosa (RP)

Interventional
See the trial
voir la fiche
NCT04295304 - Terminated

Safety and Performance Evaluation of the NR600 System in Subjects With End-stage Inherited Outer Retinal Degenerative Diseases

Interventional
See the trial
voir la fiche
NCT04423718 - Completed

Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche
NCT03683251 - Recruiting, Active

A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Portal)

Interventional
See the trial
voir la fiche